The role of tumor-associated macrophages in remodeling tumor immune microenvironment

Tumor

Volumn 33, Issue 10, 2013, Pages 922-927

  Guo, Qiu Jun ^a   Li, Jie ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Immunotherapy, tumor; Macrophages; Neoplastic microenvironment; Neoplastic processes; Tumor escape

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ANGIOGENESIS; CANCER IMMUNOTHERAPY; EXTRACELLULAR MATRIX; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHANGIOGENESIS; MOLECULARLY TARGETED THERAPY; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

EID: 84887256690     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2013.10.014     Document Type: Review

References (52)

1. CARAS I, TUCUREANU C, LERESCU L, et al. Influence of tumor cell culture supernatants on macrophage functional polarization: in vitro models of macrophage-tumor environment interaction[J]. Tumori, 2011, 97(5):647-654.
2. REDENTE E F, DWYER-NIELD L D, MERRICK D T, et al. Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization[J]. Am J Pathol, 2010, 176(6):2972-2985.
3. DOMÍNGUEZ-SOTO A, SIERRA-FILARDI E, PUIG-KRÖGER A, et al. Dendritic cell-specific ICAM-3-grabbing non-integrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10[J]. J Immunol, 2011, 186(4):2192-2200.
4. LIU L, GE D, MA L, et al. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer[J]. J Thorac Oncol, 2012, 7(7):1091-1100.
5. BERGENFELZ C, MEDREK C, EKSTRÖM E, et al. Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients[J]. J Immunol, 2012, 188(11):5448-5458.
6. TAI S K, CHANG H C, LAN K L, et al. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages[J]. J Immunol, 2012, 188(5):2464-2471.
7. KWONG C, GILMAN-SACHS A, BEAMAN K. Tumor-associated a2 vacuolar ATPase acts as a key mediator of cancer-related inflammation by inducing pro-tumorigenic properties in monocytes[J]. J Immunol, 2011, 186(3):1781-1789.
8. SHARDA D R, YU S, RAY M, et al. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase[J]. J Immunol, 2011, 187(5):2181-2192.
9. CHEN W, MA T, SHEN X N, et al. Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway[J]. Cancer Res, 2012, 72(6):1363-1372.
10. PELLO O M, DE PIZZOL M, MIROLO M, et al. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology[J]. Blood, 2012, 119(2):411-421.
11. SOLINAS G, SCHIAREA S, LIGUORI M, et al. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility[J]. J Immunol, 2010, 185(1):642-652.
12. MUNARI F, LONARDI S, CASSATELLA M A, et al. Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma[J]. Blood, 2011, 117(24):6612-6616.
13. EGEBLAD M, WERB Z. New functions for the matrix metalloproteinases in cancer progression[J]. Nat Rev Cancer, 2002, 2(3):161-174. (Pubitemid 37328786)
14. GUIET R, VAN GOETHEM E, COUGOULE C, et al. The process of macrophage migration promotes matrix metalloproteinase-independent invasion by tumor cells[J]. J Immunol, 2011, 187(7):3806-3814.
15. MENG C D, ZHU D D, JIANG X D, et al. Overexpression of interleukin-17 in tumor-associated macrophages is correlated with the differentiation and angiogenesis of laryngeal squamous cell carcinoma[J]. Chin Med J (Engl), 2012, 125(9):1603-1607.
16. SÁNCHEZ-MARTÍN L, ESTECHA A, SAMANIEGO R, et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression[J]. Blood, 2011, 117(1):88-97.
17. OJALVO L S, WHITTAKER C A, CONDEELIS J S, et al. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors[J]. J Immunol, 2010, 184(2):702-712.
18. DE-PALMA M, NALDINI L. Angiopoietin-2 TIEs up macrophages in tumor angiogenesis[J]. Clin Cancer Res, 2011, 17(16):5226-5232.
19. ESPINOSA I, EDRIS B, LEE C H, et al. CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis[J]. Am J Pathol, 2011, 179(4):2100-2107.
20. DING M, FU X, TAN H, et al. The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer[J]. Mol Med Report, 2012, 6(5):1023-1029.
21. ZHANG B, YAO G, ZHANG Y, et al. M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma[J]. Clinics (Sao Paulo), 2011, 66(11):1879-1886.
22. QING W, FANG WY, YE L, et al. Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma[J]. Thyroid, 2012, 22(9):905-910.
23. KURAHARA H, TAKAO S, MAEMURA K, et al. M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer[J]. Pancreas, 2013, 42(1):155-159.
24. WU H, XU J B, HE Y L, et al. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer[J]. J Surg Oncol, 2012, 106(4):462-468.
25. COSTA N L, VALADARES M C, SOUZA P P, et al. Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma[J]. Oral Oncol, 2013, 49(3):216-223.
26. TAKAMIYA R, OHTSUBO K, TAKAMATSU S, et al. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-? secretion from monocytes/macrophages through the DAP12-Syk pathway[J]. Glycobiology, 2013, 23(2):178-187.
27. KRNETA T, GILLGRASS A, ASHKAR A A. The influence of macrophages and the tumor microenvironment on natural killer cells[J]. Curr Mol Med, 2013, 13(1):68-79.
28. MASSI D, MARCONI, FRANCHI A, et al. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors[J]. Hum Pathol, 2007, 38(10):1516-1525. (Pubitemid 47418963)
29. STEIDL C, LEE T, SHAH S P, et al. Tumor-associated macrophages and survival in classic Hodgkin?s lymphoma[J]. N Engl J Med, 2010, 362(10):875-885.
30. TAN K L, SCOTT D W, HONG F, et al. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial[J]. Blood, 2012, 120(16):3280-3287.
31. ITO M, ISHII G, NAGAI K, et al. Prognostic impact of cancer-associated stromal cells in patients with stage? lung adenocarcinoma[J]. Chest, 2012, 142(1):151-158.
32. THÖM I, ANDRITZKY B, SCHUCH G, et al. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic non-small cell lung cancer[J]. Cancer, 2010, 116(17):4114-4121.
33. CHUNG F T, LEE K Y, WANG C W, et al. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer[J]. Int J Cancer, 2012, 131(3):E227-E235.
34. KURAHARA H, TAKAO S, KUWAHATA T, et al. Clinical significance of folate receptor ?-expressing tumor-associated macrophages in pancreatic cancer[J]. Ann Surg Oncol, 2012, 19(7):2264-2271.
35. YOSHIKAWA K, MITSUNAGA S, KINOSHITA T, et al. Impact of tumor-associated macrophages on invasive ductal carcinoma of the Pancreas head[J]. Cancer Sci, 2012, 103(11):2012-2020.
36. MEDREK C, PONTÉN F, JIRSTRÖM K, et al. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients[J]. BMC Cancer, 2012, 12:306.
37. JIANG X F, TANG Q L, SHEN X M, et al. Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma[J]. Pathol Res Pract, 2012, 208(12):730-735.
38. JIANG X F, TANG Q L, LI H G, et al. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma[J]. J Obstet Gynaecol Res, 2013, 39(4):855-863.
39. GRUGAN K D, MCCABE F L, KINDER M, et al. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function[J]. J Immunol, 2012, 189(11):5457-5466.
40. HUANG Z, YANG Y, JIANG Y, et al. Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers[J]. Biomaterials, 2013, 34(3):746-755.
41. PICKERT G, LIM H Y, WEIGERT A, et al. Inhibition of GTP cyclohydrolase attenuates tumor growth by reducing angiogenesis and M2-like polarization of tumor associated macrophages[J]. Int J Cancer, 2013, 132(3):591-604.
42. SPEAR P, BARBER A, RYNDA-APPLE A, et al. Chimeric antigen receptor T cells shape myeloid cell function within the tumor microenvironment through IFN-γ and GM-CSF[J]. J Immunol, 2012, 188(12):6389-6398.
43. ERUSLANOV E, KALIBEROV S, DAURKIN I, et al. Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer[J]. J Immunol, 2009, 182(12):7548-7557.
44. RAI R K, VISHVAKARMA N K, MOHAPATRA T M, et al. Augmented macrophage differentiation and polarization of tumor-associated macrophages towards M1 subtype in listeria-administered tumor-bearing host[J]. J Immunother, 2012, 35(7):544-554.
45. MACDONALD K P, PALMER J S, CRONAU S. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation[J]. Blood, 2010, 116(19):3955-3963.
46. ROTH F, DE LA FUENTE A C, VELLA J L, et al. Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression[J]. Cancer Res, 2012, 72(6):1373-1383.
47. SONG L, ASGHARZADEH S, SALO J, et al. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages[J]. J Clin Invest, 2009, 119(6):1524-1536.
48. SZABÓ I. Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels[J]. Curr Med Chem, 2012, 19(31):5394-5404.
49. RODA J M, WANG Y, SUMNER L A, et al. Stabilization of HIF2α induces sVEGFR1 production from tumorassociated macrophages and decreases tumor growth in a murine melanoma model[J]. J Immunol, 2012, 189(6):3168-3177.
50. HUANG Z, YANG Y, JIANG Y, et al. Antitumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers[J]. Biomaterials, 2013, 34(3):746-755.
51. LIU D, SONG L, WEI J, et al. IL15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity[J]. J Clin Invest, 2012, 122(6):2221-2233.
52. YANG W, LU Y, XU Y, et al. Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor associated macrophages (TAMs)[J]. J Biol Chem, 2012, 287(48):401-409.